With clinical research units throughout the US and Europe, we enroll people to participate in the clinic.
02/27/2026
🔬 February 28 is Rare Disease Day. At Fortrea, we’re proud to continue advancing research that brings hope to rare disease communities worldwide.
With hundreds of rare disease studies supported in recent years, our teams remain dedicated to accelerating breakthroughs and expanding what’s possible in clinical science. 💡
02/24/2026
Clinical trials change lives — be part of the change! Call us at 1-866-429-3700 to see if you qualify.
02/19/2026
Your participation matters. Learn how to join a study by calling 1‑866‑429‑3700. 💚
02/17/2026
Before joining a study, it helps to know what to expect so you can make a confident, informed decision. Our team is ready to answer any questions—call 1‑866‑429‑3700 or visit fortreaclinicaltrials.com. 💚
02/14/2026
Share the love this Valentine's Day by participating in a clinical trial! ❤️
Learn more and browse available studies at FortreaClinicalTrials.com
02/10/2026
❌MYTH: You must have a condition to participate in a clinical trial.
✅FACT: Fortrea Clinical Trials conducts Phase 1 studies, for healthy participants. These studies help researchers determine the best dosing, timing and administration for a new treatment and also provide insights into how the drug reacts with the body.
02/06/2026
With our Refer-a-Friend program, you can score big no matter who wins the big game. 🏈💚
Earn up to $500 per qualified referral. Learn more at FortreaClinicalTrials.com
02/04/2026
Today is — a day dedicated to raising awareness about prevention, early detection, and treatment. 🧪
On this World Cancer Day, Fortrea honors the relentless spirit of those fighting cancer, remembers those we’ve lost, and recognizes the vital role of clinical research in advancing prevention and treatment.
01/29/2026
FAQ: What if I change my mind? 🤔
01/27/2026
Help advance medical research by spreading the word to others. 👥
To qualify, your friend must:
- Be new to Fortrea Clinical Trials or have not screened or participated in a clinical trial with Fortrea in the last 12 months
- Complete a screening appointment
- Fill out a Refer a Friend form at their screening appointment
- Qualify as a study participant
01/22/2026
Unlocking the future of medicine 🔓
When you participate in a clinical trial, you can help contribute to life-changing research!
01/19/2026
Celebrating the life and legacy of Martin Luther King Jr.
Be the first to know and let us send you an email when Fortrea Clinical Trials - Madison posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development companies. With the most comprehensive portfolio of preclinical, clinical development and commercialization services, Covance provides industry-leading services, the world’s largest central laboratory network, and a global team of clinical research and commercialization experts.
With clinical research units throughout the US and Europe, we enroll people to participate in clinical research studies to test new investigational products, and approved medications for new treatments. Covance Clinical Research Units are part of the Phase I/IIa drug development portion of Covance.
What We Do
Covance carries out clinical research studies on behalf of the world's leading pharmaceutical and biotechnology organizations. As more drugs are being discovered, more people are needed to participate in clinical research studies.
Conduct of Studies
Clinical research studies at Covance are conducted by a group of medically trained staff, including doctors and nurses, who monitor your safety during your participation.
Worldwide drug authorities have regulations to protect clinical research study participants and standards for how trials are conducted. It is required that participants are told what the purpose of the study is, what will happen during the study, risks and benefits of study participation, and background information on the investigational medication, including other studies involving the medication. An independent ethics board reviews the study, including all documents a participant will read and sign to make sure appropriate safeguards are in place. Study participation is always 100% voluntary from start to finish.
Types of Studies
Clinical research studies are classified into four phases defined by worldwide authorities.
Phase I studies, including First-In-Human studies, are conducted in a small number of healthy participants to determine safety and tolerability. These studies test how drugs are absorbed into the body, as well as the amount of time the drug stays in the body. Safety of the drug and side effects are evaluated at varying dose levels. Additionally, interactions among multiple drugs, equivalence of a generic drug to a marketed drug and the effect of food on how the drug moves through the body may be studied.
Phase II studies also involve a limited number of participants and help provide an early indication for whether the drug shows promise in treating the condition for which it is being developed. These studies involve participants who have mild-to-moderate forms of the condition the drug is designed to treat, but who are otherwise healthy. Examples include:
People with diabetes, asthma and high blood pressure
Healthy post menopausal women
Healthy elderly
Phase III studies include thousands of participants with the disease or medical condition the drug is being developed to treat. These studies determine safety and effectiveness. They may compare the study drug to a current marketed treatment. Healthy individuals may participate in Phase III studies for smoking cessation, insomnia, vaccinations, weight loss, etc.
Phase IV studies involve further testing in large numbers of individuals after the product is released on the market.
